Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Breakthrough antibody therapy shows significant promise against drug-resistant multiple myeloma

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute and other organizations report today online in the New England Journal of Medicine.

27 Aug 2015

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes a case-series of eight British health-care workers who were evacuated to the Royal Free Hospital in London, UK after possible accidental exposure to Ebola virus in Sierra Leone between January and March 2015.

26 Aug 2015

Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

26 Aug 2015

Researchers discover new hepatitis A-like virus in seals

Scientists in the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A.

26 Aug 2015

Flu remedies can help treat E. coli bacteria

If the intestinal bacteria level becomes unbalanced, it can cause diseases. Physiologists from the University of Zurich reveal how a specific carbohydrate in the intestinal mucosa heavily multiplies certain E. coli bacteria and thus causes inflammations. These could be treated with flu remedies, which opens up new therapeutic possibilities.

26 Aug 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen today announced that it will present six abstracts at the upcoming ESC Congress 2015, organized by the European Society of Cardiology, being held Aug. 29 – Sept. 2 in London.

26 Aug 2015

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.

26 Aug 2015

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia Pharmaceuticals, Inc. today announced the initiation of enrollment of children as young as 6 years old in the company's ongoing Phase 2 study of palovarotene for the treatment of fibrodysplasia ossificans progressiva (FOP).

26 Aug 2015

MNX Global Logistics' new Life Sciences Logistics Centre opens in Amsterdam

MNX Global Logistics announces the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol. This facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for our Life Sciences and Medical Device customers throughout Europe.

25 Aug 2015

Significant divide can exist between patients and physicians about same medical terms

Few things are more stressful than dealing with a sick child. From discussing treatment with a pediatrician to complying with day care policies, a parent must consider many factors when making a decision about their child's health. Now, a recent study from the University of Missouri and the University of Michigan is shedding light on the significant divide that can exist between patients and physicians about the same terminology--especially when it comes to discussing "pink eye," a particular flashpoint in childcare.

25 Aug 2015

Study: Influenza vaccines offer sustained protection up to 6 months during flu season

Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases.

25 Aug 2015

New study affirms value of influenza vaccination among older people

A new study of the records of millions of nursing home residents affirms the value of influenza vaccination among the elderly. The Brown University analysis found that between 2000 and 2009, the better matched the vaccine was for the influenza strain going around, the fewer nursing home residents died or were hospitalized.

25 Aug 2015

TSRI, Janssen collaborate to find universal flu vaccine

Scientists from The Scripps Research Institute and the Janssen Pharmaceutical Companies of Johnson & Johnson have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

24 Aug 2015

Regenstrief to highlight open source options for health information exchange, data analysis at MedInfo 2015

Regenstrief Institute investigators experienced in the use of data to improve health care and its delivery in resource constrained environments will introduce attendees at MedInfo 2015 to open source options for health information exchange and data analysis.

21 Aug 2015

Social and environmental processes linked to 2009 H1N1 pandemic outbreaks in Mexico

Scientists studying the 2009 A/H1N1 influenza pandemic have found that the inconsistent regional timing of pandemic waves in Mexico was the result of interactions between school breaks and regional variations in humidity.

21 Aug 2015

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.

20 Aug 2015

60P to commence Phase II clinical trial among dengue fever patients

60 Degrees Pharmaceuticals, a company focused on development of therapeutics for tropical diseases, and Singapore General Hospital announced today that the Hospital has received a grant from Singapore's National Medical Research Council to support a Phase II clinical trial among dengue fever patients.

20 Aug 2015

Energy-burning 'good' fat helps reduce weight gain, lower blood glucose levels in mice

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.

20 Aug 2015

Experimental MERS-CoV vaccine shows promise in monkeys and camels

National Institutes of Health scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease. The vaccine also generated potentially protective MERS-CoV antibodies in blood drawn from vaccinated camels.

20 Aug 2015

H1N1 vaccine developed at UNMC to be evaluated in animal study

An H1N1 vaccine developed at the University of Nebraska Medical Center will enter a definitive round of testing this month, and researchers hope to establish its ability to ward off the virus.

20 Aug 2015

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Breakthrough antibody therapy shows significant promise against drug-resistant multiple myeloma

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Long lasting flu vaccine using antibodies advance from TSRI and Janssen

Researchers discover new hepatitis A-like virus in seals

Flu remedies can help treat E. coli bacteria

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

MNX Global Logistics' new Life Sciences Logistics Centre opens in Amsterdam

Significant divide can exist between patients and physicians about same medical terms

Study: Influenza vaccines offer sustained protection up to 6 months during flu season

New study affirms value of influenza vaccination among older people

TSRI, Janssen collaborate to find universal flu vaccine

Regenstrief to highlight open source options for health information exchange, data analysis at MedInfo 2015

Social and environmental processes linked to 2009 H1N1 pandemic outbreaks in Mexico

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

60P to commence Phase II clinical trial among dengue fever patients

Energy-burning 'good' fat helps reduce weight gain, lower blood glucose levels in mice

Experimental MERS-CoV vaccine shows promise in monkeys and camels

H1N1 vaccine developed at UNMC to be evaluated in animal study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in